Allergy & Immunology CE Activities

RMEI Presentations


RSS Latest Allergy & Immunology Articles
  • Being Seen March 30, 2023
    In this episode of “NOS,” Lisa Rosenbaum talks with Meghan O’Rourke, author of The Invisible Kingdom: Reimagining Chronic Illness, about her journalistic investigation of her own illness, trust in health care, and how cultural narratives affect our experiences of illness.
  • Vedolizumab for the Treatment of Chronic Pouchitis March 30, 2023
    In a phase 4, double-blind, randomized trial, vedolizumab therapy was more effective than placebo in inducing remission in patients with chronic pouchitis after ileal pouch–anal anastomosis for ulcerative colitis.
    Simon Travis, Mark S. Silverberg, Silvio Danese, Paolo Gionchetti, Mark Löwenberg, Vipul Jairath, Brian G. Feagan, Brian Bressler, Marc Ferrante, Ailsa Hart, Dirk Lindner, Armella Escher, Stephen Jones, Bo Shen, the EARNEST Study Group
  • Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis March 23, 2023
    In the induction period of two phase 3 trials, 16 weeks of treatment with lebrikizumab was effective in adolescents and adults with moderate-to-severe atopic dermatitis.
    Jonathan I. Silverberg, Emma Guttman-Yassky, Diamant Thaçi, Alan D. Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L. Simpson, Chia-Yu Chu, Zhuqing Liu, Renata Gontijo Lima, Sreekumar G. Pillai, Julien Seneschal, the ADvocate1 and ADvocate2 Investigators


View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Previously Published CE Activities